(Q72128352)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6987534%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

title

Luteinising hormone-releasing and anti-fertility properties of a glucagon-selective somatostatin analogue (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6987534%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

author name string

F J Bex

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6987534%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

A Corbin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6987534%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

D Sarantakis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6987534%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

E Lien

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6987534%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

language of work or name

English

0 references

publication date

1 March 1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6987534%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6987534%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6987534%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

5754

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6987534%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

342-343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6987534%20AND%20SRC:MED&resulttype=core&format=json

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

24 October 2019

cites work

1 reference

7 January 2021

Somatostatin: physiological and clinical significance

1 reference

7 January 2021

Inhibition of insulin secretion by somatostatin

1 reference

7 January 2021

Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics

1 reference

7 January 2021

The essential role of glucagon in the pathogenesis of diabetes mellitus

1 reference

7 January 2021

Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.

1 reference

7 January 2021

Inhibition of growth hormone secretion in the rat by synthetic somatostatin

1 reference

7 January 2021

Hyperglycemia induced by somatostatin in normal subjects

1 reference

7 January 2021

The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics

1 reference

7 January 2021

D-Trp8-somatostatin: An analog of somatostatin more potent than the native molecule

1 reference

7 January 2021

A novel cyclic undercapeptide, WY-40, 770, with prolonged growth hormone release inhibiting activity

1 reference

7 January 2021

Prolonged suppression of insulin release by a somatostatin analog

1 reference

7 January 2021

Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analog

1 reference

7 January 2021

Somatostatin: analogs with selected biological activities

1 reference

7 January 2021

Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release

1 reference

7 January 2021

[des-Ala1, Gly2]-His4,5D-Trp8-somatostatin: a glucagon-specific and long-acting somatostatin analog

1 reference

7 January 2021

Treatment of Streptozotocin-Diabetic Dogs With a Long-Acting Somatostatin Analog

1 reference

7 January 2021

Peptide Contraception: Antifertility Properties of LH-RH Analogues

1 reference

7 January 2021

Mechanism of the Postcoital Contraceptive Effect of Luteinizing Hormone-Releasing Hormone: Ovarian Luteinizing Hormone Receptor Interactions*

1 reference

7 January 2021

Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropin

1 reference

7 January 2021

Inhibition of spermatogenesis in the rat by treatment with [D-Ala6, Des-Gly-NH210] LHRH ethylamide

1 reference

7 January 2021

Fluctuations in plasma testosterone levels in adult male rats and mice

1 reference

7 January 2021

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly

1 reference

7 January 2021

Inhibition of growth hormone release in humans by somatostatin

1 reference

7 January 2021

Extrapituitary Action of Gonadotropin-Releasing Hormone: Direct Inhibition Ovarian Steroidogenesis

1 reference

7 January 2021

(DTrp6-Pro9-NEt)-luteinising hormone-releasing factor inhibits follicular development in hypophysectomised rats

1 reference

7 January 2021

Identifiers

DOI

10.1038/284342A0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6987534%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference